AstraZeneca Pharma India Reports Resignations of Senior Management Personnel
AstraZeneca Pharma India Limited has confirmed the resignations of two senior management personnel, Ms. Aditi Mehta and Mr. Srikanth B.S., as both pursue career opportunities outside the organization. The changes are effective on different dates.Ms. Aditi Mehta, who held the position of Business Unit Director for the Oncology Business Unit, will be relieved from her duties by the close of business hours on June 12, 2026. AstraZeneca Pharma India Limited is actively seeking a suitable replacement for this key role.
Mr. Srikanth B.S., Site Lead for India Operations, is scheduled to complete his handover period and cease his duties effective at the close of business hours on June 15, 2026.
These individuals tendered their resignations citing a desire to pursue career opportunities outside the company.
The details of these changes involving the key personnel are summarized below:
| Name & Designation | Reason for Change | Date of Cessation |
|---|---|---|
| Ms. Aditi Mehta, Business Unit Director - Oncology Business Unit | Resignation to pursue career outside the Company. | June 12, 2026 |
| Mr. Srikanth B.S., Site Lead, India Operations | Resignation to pursue his career outside the Company. | June 15, 2026 |
The company has extended its best wishes to both personnel for their future endeavors.
ASTRAZEN Stock Price Movement
Shares of AstraZeneca Pharma India Limited are edging higher to ₹8236 as of 12:32 PM today, driven by a gain of 0.09%. The stock is trading in the live market, with total volume reaching 1,302 shares thus far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.